Qitan Tech
Latest round
- Series C
Last raised
- Dec 2023
Total raised
- $191M
Investors
- 17
About Qitan Tech
, trading as Qitan Tech, is a biotechnology company that focuses on gene sequencing and gene diagnostics through nanotechnology. The founder, Dr. Bai Jinwei, is a postdoctoral fellow in the IBM Watson Laboratory. The company released the domestic nanopore gene sequencer QNome-9604 in 2020. The branch offices were set up in Beijing, Chengdu, and other places. In August 2023, QPursue, a medium flux nanopore sequencing platform was released. The company’s products include nanopore sequencing, nanopore sequencers, flowcells & reagents, and nanopore sequencing software. The products can be used in pathogen research, tumor research genetic disease research, and so on. Its technology is applied in fields of biopharmaceuticals, pathogen infection, rare diseases, cancer detection, reproductive health, and agricultural and animal husbandry economies. The company's revenue is generated by providing nanopore sequencers.
Who invested in Qitan Tech
17 investors across 5 rounds
See all investors in Qitan Tech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Qitan Tech
Who invested in Qitan Tech?
Qitan Tech has 17 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Qitan Tech raised?
Qitan Tech has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Qitan Tech last raise money?
Qitan Tech's most recent round on record is a Series C, in Dec 2023.
What does Qitan Tech do?
, trading as Qitan Tech, is a biotechnology company that focuses on gene sequencing and gene diagnostics through nanotechnology.
Where is Qitan Tech headquartered?
Qitan Tech is headquartered in Chengdu, China.
Which VCs invest in companies like Qitan Tech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Qitan Tech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Qitan Tech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.